There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.

Clinical Trials

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 26
Start Date: March 31, 2020

A Single-arm, Multiple Centers, Phase II Study Evaluating Rituximab in Combination With Chidamide and Lenalidomide for Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma (AITL)

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 40
Start Date: February 4, 2019

A Phase 1/2 Study of Pembrolizumab Plus Pralatrexate for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphomas

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 23
Start Date: December 29, 2018

A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Chidamide Combined With CHOP(Cyclophosphamide, Doxorubicin, Vincristine, Prednisone ) in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 86
Start Date: November 9, 2018

Randomized Phase 3 Study Evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patient With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma

View All Clinical Trials